Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma

Our study revealed the central role of the miR-107/KIF23 axis in controlling tumor cell fitness and hepatocellular carcinoma progression. The results demonstrate that the overexpression of miR-107 or silencing of its target, KIF23, markedly suppresses the proliferation, survival, and motility of human and mouse hepatoma cells. In this work, we demonstrate that the disruption of miR-107/Kif23 signaling effectively protects mice from an aggressive form of oncogene-induced liver cancer in vivo, implying that targeting miR-107/KIF23 might be a novel therapeutic approach for hepatocellular carcinoma in humans.

Authors

Institutions

Publication Details

Journal
Journal of Hepatology
Published
2024-08-31
DOI
https://doi.org/10.1016/j.jhep.2024.08.025
Citations
6
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
1.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma

Tom Luedde, Lara R. Heij, Mathias Heikenwälder, Johannes G. Bode et al.
6 citations
Journal of Hepatology
MicroRNA in disease regulation
1.71
article

Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma

Tom Luedde, Lara R. Heij, Mathias Heikenwälder, Johannes G. Bode, Sanchari Roy, Ahmed Ghallab, Jan Georg Hengstler, Thomas Longerich, Wiebke Albrecht, Lars Zender, Matthias A. Dille, Rossella Pellegrino, M. Castoldi, Stephanie D. Wolf, Mihael Vucur, Wolfram Trudo Knoefel, Ulf P. Neumann, Veronika Buettner, Carolin Angendohr, Christoph Roderburg, Michael T. Singer, Georg Flügen
article en
6 citations

Abstract

Our study revealed the central role of the miR-107/KIF23 axis in controlling tumor cell fitness and hepatocellular carcinoma progression. The results demonstrate that the overexpression of miR-107 or silencing of its target, KIF23, markedly suppresses the proliferation, survival, and motility of human and mouse hepatoma cells. In this work, we demonstrate that the disruption of miR-107/Kif23 signaling effectively protects mice from an aggressive form of oncogene-induced liver cancer in vivo, implying that targeting miR-107/KIF23 might be a novel therapeutic approach for hepatocellular carcinoma in humans.

Journal of HepatologyVol. 82(3)
German Cancer Research Center (DE), South Valley University (EG), TU Dortmund University (DE), Heidelberg University (DE), Erasmus MC (NL), University Hospital Heidelberg (DE), Düsseldorf University Hospital (DE), Essen University Hospital (DE), University Children's Hospital Tübingen (DE), Leibniz Research Centre for Working Environment and Human Factors (DE), Heinrich Heine University Düsseldorf (DE), RWTH Aachen University (DE)
European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Gesundheit, Deutsche Krebshilfe, Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen, H2020 European Research Council
Good health and well-being
Openalex Percentile: Top 15%
MicroRNA in disease regulation
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.